ATNM Q1 2026 Earnings NarrowerthanExpected Loss Reflects Cost Discipline Amid IomabB Development LIVN Q1 2026 Earnings EPS Beats Estimates by 714 Stock Declines Slightly CIA Q1 2026 Earnings EPS Miss Triggers Cautious Market Response IPM Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Despite Positive Stock Reaction CYCN Q4 2025 Earnings Narrowed Losses Exceed Expectations as Development Programs Progress